Rigel Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 1.75 M | $29.40 M | 11.95% | 9.93% |
ARMISTICE CAPITAL, LLC | 02/14/2025 | 1.15 M | $19.38 M | -25.00% | 6.55% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.13 M | $19.02 M | 20.96% | 6.42% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 410,778 | $6.91 M | -7.01% | 2.33% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 376,366 | $6.33 M | -10.77% | 2.14% |
CM MANAGEMENT, LLC | 02/07/2025 | 242,500 | $4.08 M | -16.38% | 1.38% |
HILLSDALE INVESTMENT MANAGEMENT INC. | 02/11/2025 | 170,100 | $2.86 M | 814.52% | 0.97% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 139,128 | $2.34 M | 41.96% | 0.79% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 117,957 | $1.98 M | 100.00% | 0.67% |
DLD ASSET MANAGEMENT, LP | 02/12/2025 | 100,000 | $28,010 | 100.00% | 0.57% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 86,001 | $1.45 M | 15.43% | 0.49% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 85,878 | $1.44 M | 100.00% | 0.49% |
ZACKS INVESTMENT MANAGEMENT | 02/13/2025 | 85,423 | $1.44 M | 100.00% | 0.49% |
UBS OCONNOR LLC | 02/14/2025 | 84,311 | $1.42 M | -27.89% | 0.48% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 72,451 | $1.22 M | 151.04% | 0.41% |
HRT FINANCIAL LP | 02/14/2025 | 68,191 | $1.15 M | 100.00% | 0.39% |
SQUAREPOINT OPS LLC | 02/14/2025 | 63,416 | $1.07 M | 40.12% | 0.36% |
GLOBEFLEX CAPITAL L P | 02/10/2025 | 52,295 | $879,602 | 468.42% | 0.30% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 44,171 | $742,956 | 100.00% | 0.25% |
02/28/2025 | 40,200 | $676,164 | 100.00% | 0.23% | |
SEGALL BRYANT & HAMILL, LLC | 02/11/2025 | 36,259 | $609,876 | 100.00% | 0.21% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 30,840 | $518,000 | 54.11% | 0.18% |
JUMP FINANCIAL, LLC | 02/13/2025 | 30,035 | $505,189 | 96.50% | 0.17% |
02/10/2025 | 23,700 | $398,634 | 777.78% | 0.13% | |
FRANKLIN RESOURCES INC | 02/12/2025 | 21,809 | $366,828 | 70.84% | 0.12% |
WALLEYE CAPITAL LLC | 02/13/2025 | 21,621 | $363,665 | 100.00% | 0.12% |
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 02/06/2025 | 20,000 | $336,400 | 0.00% | 0.11% |
PDT PARTNERS, LLC | 02/14/2025 | 19,829 | $333,524 | -0.43% | 0.11% |
MAN GROUP PLC | 02/14/2025 | 18,156 | $305,384 | -29.07% | 0.10% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 15,953 | $268,329 | 100.00% | 0.09% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 15,483 | $260,000 | 100.00% | 0.09% |
ALPS ADVISORS INC | 02/13/2025 | 14,240 | $239,517 | 100.00% | 0.08% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 13,418 | $225,691 | -85.81% | 0.08% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 12,609 | $212,083 | 100.00% | 0.07% |
EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC | 02/14/2025 | 12,000 | $201,840 | -15.79% | 0.07% |
CONNECTICUT WEALTH MANAGEMENT, LLC | 02/18/2025 | 11,520 | $193,766 | 0.00% | 0.07% |
SHERBROOKE PARK ADVISERS LLC | 02/14/2025 | 11,075 | $186,282 | 100.00% | 0.06% |
XTX TOPCO LTD | 02/13/2025 | 10,910 | $183,506 | 100.00% | 0.06% |
02/13/2025 | 10,759 | $180,966 | 100.00% | 0.06% | |
GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 10,086 | $169,647 | 100.00% | 0.06% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 9,902 | $166,552 | 2.89% | 0.06% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 8,653 | $145,543 | -7.03% | 0.05% |
02/11/2025 | 5,056 | $85,042 | 100.00% | 0.03% | |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 3,735 | $62,823 | 100.00% | 0.02% |
PICTON MAHONEY ASSET MANAGEMENT | 02/10/2025 | 1,297 | $22,000 | 2.05% | 0.01% |
FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 667 | $11,219 | 0.00% | 0.00% |
AMALGAMATED BANK | 02/04/2025 | 588 | $10,000 | 0.00% | 0.00% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 587 | $9,686 | 100.00% | 0.00% |
CULLEN/FROST BANKERS, INC. | 02/06/2025 | 402 | $6,762 | 100.00% | 0.00% |
02/19/2025 | 370 | $6,223 | 100.00% | 0.00% |
Rigel Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 114 institutional investors and hedge funds held shares of Rigel Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 1.75 M
ARMISTICE CAPITAL, LLC: 1.15 M
Soleus Capital Management, L.P.: 1.13 M
Assenagon Asset Management S.A.: 410,778
ACADIAN ASSET MANAGEMENT LLC: 376,366
CM Management, LLC: 242,500
68.52% of Rigel Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 23.15 M shares in the last 24 months. This purchase volume represents approximately $384.32 M in transactions.